Parker-Hannifin CapEx increased by 9.6% to $103.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.5%, from $87.66M to $103.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 20.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.89M | $48.20M | $57.40M | $53.26M | $71.18M | $83.56M | $102.15M | $86.90M | $108.14M | $97.75M | $106.37M | $79.21M | $116.78M | $95.30M | $121.19M | $87.66M | $130.85M | $89.00M | $94.00M | $103.00M |
| QoQ Change | — | -34.8% | +19.1% | -7.2% | +33.7% | +17.4% | +22.3% | -14.9% | +24.4% | -9.6% | +8.8% | -25.5% | +47.4% | -18.4% | +27.2% | -27.7% | +49.3% | -32.0% | +5.6% | +9.6% |
| YoY Change | — | — | — | — | -3.7% | +73.3% | +78.0% | +63.2% | +51.9% | +17.0% | +4.1% | -8.8% | +8.0% | -2.5% | +13.9% | +10.7% | +12.0% | -6.6% | -22.4% | +17.5% |